7Cortesi N, Ferrari P, Zambarda E, et al. Diagnosis of bilateral abdominal cryptorchidism by laparoscopy. Endoscopy, 1976, 8~ 33-34.
8Clayman R V, Kavoussi I. R, Soper N J, et al. Laparoscopic nephrectomy: initial case report. J Urol. 1991, 146: 278- 282.
9Bannenberg J J G, Meijer D W, Bannenberg J H, et al. Hand assisted laparoseoic nephreetomy in the pig: initial re port. Min Invas Ther Allied Technol, 1996, 5:483-487.
10Nakada S Y, Moon T D, Gist M, et al. Use of the pneumo sleeve as an adjunct in laparoscopic nephrectomy. Urology, 1997, 49:612-613.
二级参考文献29
1Rane A, Kommu S, Eddy B, et al. Clinical evaluation of a novel laparoscopic port (R-port) and evolution of the single laparoscopic port procedure ( SLiPP). J Endourol,2007,21 Suppl 1 : A22-23.
2Ramau JD, Bensalah K, Bagrodia A, et al. Laboratory and clinical development of single keyhole umbilical nephrectomy. Urology, 2007,70 : 1039-1042.
3Desai MM, Rao PP, Aron M, et al. Scarless single port transumbilical nephrectomy and pyeloplasty: first clinical report. BJU Int, 2008,101: 83-88.
4Desai MM, Stein RJ, Rao P, et al. Embryonic natural orifice surgery (E-NOTES) for advanced reconstruction: initial experience. Urology, 2009,73 : 182 -187.
5[2]Jackman S V, Docimo S G,Cadeddu J A,et al. The "mini-perc" technique: a less invasive alternative to percutaneous nephrolithotomy. World J Urol,1998, 16: 371-374.
7Rassweiler J,Alken P.ESWL'90-State of the art.Limitations and future trends of shock wave lithotripsy.Urol Res,1990,18:13～24
8Rassweiler J,Henkel TO,K(o)hrmann KU,et al.Lithotriptor technology:present and future.J Endourol,1992,6:1～13
9Rassweiler J,K(o)hrmann KU,Heine G,et al.Modulith SL 10/20-Experimental introduction and first clinical experience with a new interdisciplinary lithotripter.Eur Urol,1990,18:237～241
10Tailly GG.Consecutive experience with four Dornier lithotripters:HM4,MPL9000,Compact and U/50.J Endourol,1999,13:329～338
6SCHRODER F H. Progress in understanding androgenindependent prostate cancer (AIPC): a review of potential endocrine-mediated mechanisms[J]. Eur Urol, 2008, 53(6): 1129-1137.
7CHOW C. OncomiRs: the discovery and progress of microRNAs in cancers[J].Mol Cancer, 2007, 6: 60.
8BONKHOFF H, FIXEMER T. Neuroendocrine differentiation in prostate cancer: an unrecognized and therapy resistant phenotype[J]. Pathologe, 2005, 26 (6) 453-460.
9MURATA T, TAKAYAMA K, KATAYAMA S, et al. miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression[J]. Prostate Cancer Prostatic Dis, 2010,13 (4) : 356-361.
10FUJITA Y, KOJIMA K, OHHASHI R, et al. MiR-148a attenuates paclitaxel resistance of hormone-refractory, drugresistant prostate cancer PC3 cells by regulating MSK1 expression[J]. J Biol Chem, 2010, 285(25):19076-19084.
